- In May 2025, Awshad, an Indian medical cannabis brand, launched its new product line, CalmaGummies, a plant-based supplement designed to promote relaxation, focus, and restful sleep. Each gummy contains 135mg of full-spectrum hemp extract, combining CBD and THC for a balanced wellness solution. This launch marks Awshad's entry into the gummy segment and addresses the growing demand for holistic, non-invasive health alternatives in India
- In March 2024, Cannaray Limited, a European medical cannabis company, announced a definitive agreement to merge with Aqualitas Inc., a Canadian medical cannabis cultivator and processor. This merger aims to create a global, vertically integrated business, providing high-quality and consistent medical cannabis products to patients, especially in the European medical cannabis sector, leveraging recent legalization changes in Germany
- In September 2023, 4Front Ventures Corp. expanded its product offerings in Illinois under its premium flower brand, Island Cannabis Co., introducing a new 7g size of Island's premium flower and Island Classic Single Strain 1g Pre-Rolls. This expansion further solidifies 4Front's presence in key markets and caters to evolving consumer preferences for diverse cannabis formats
- In September 2023, Aurora Cannabis Inc. partnered with Herbarium, a prominent Brazilian herbal medicine company, to extend its hemp-derived CBD offerings into Brazil. This collaboration introduces a full-spectrum, single-source 3% CBD oil under the Herbarium brand, aiming to bolster Aurora Cannabis's presence and customer base in the Brazilian market
- In March 2023, Entourage Health Corp., a Canadian cannabis producer, expanded its product portfolio under Color Cannabis and Saturday Cannabis brands. The new offerings feature unique cannabis cultivars, large-format flower, and infused pre-rolls, initially available in Ontario and Alberta, with plans for a nationwide rollout, indicating a focus on product diversification and market reach
